We observed that BM ST2+ Treg cell, KLRG1+ST2+ Treg cell percentages and numbers rose over time after leukemia challenge as compared to the no tumor condition in both models (Fig. 2A, Supplementary Fig. 6). The gene discussed is IL1RL1; the disease is leukemia.